Kevin McLaughlin's profile photo

Kevin McLaughlin

New Jersey

Executive Editor at Cancer Today

Executive Editor, @CancerTodayMag. Views expressed are my own.

Articles

  • 1 week ago | cancertodaymag.org | Kevin McLaughlin

    Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A single dose of a human papillomavirus (HPV) vaccine provides similar protection from the disease as two doses, according to results of the ESCUDDO trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.

  • 2 weeks ago | cancertodaymag.org | Kevin McLaughlin

    BREAST CANCER DEATH RATES declined dramatically between 2010 and 2020 for U.S. women ages 20 to 49, according to a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. (The AACR publishes Cancer Today.)Using breast cancer data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program, researchers analyzed 11,661 breast cancer deaths in the decade between 2010 and 2020.

  • 2 weeks ago | cancertodaymag.org | Kevin McLaughlin

    ON A DAY when thousands of cancer researchers held up placards reading “Cancer Research Saves Lives” at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, researchers, former directors of federal agencies and cancer survivors discussed the crisis in federal support for research. (The AACR publishes Cancer Today.)Delays and halts in federal funds and staff layoffs at federal agencies put cancer research and future treatment breakthroughs at risk, said Patricia M.

  • 1 month ago | cancertodaymag.org | Kevin McLaughlin

    Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Testing for an experimental cell-based immune therapy that shows promise in treating gastrointestinal cancer has been delayed by layoffs among highly trained staff at the National Institutes of Health (NIH). Steven A.

  • 2 months ago | cancertodaymag.org | Kevin McLaughlin

    Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A small study has found that playing pickleball, the fastest-growing sport in the U.S., may lead to increased and sustained physical activity among cancer survivors.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
216
Tweets
479
DMs Open
No
Kevin McLaughlin
Kevin McLaughlin @CancerTodayEdit
2 Feb 23

RT @PresCancerPanel: The Panel welcomes new Chair, @DrLizJaffee! Dr. Jaffee is an expert in cancer immunology and pancreatic cancer, she is…

Kevin McLaughlin
Kevin McLaughlin @CancerTodayEdit
12 Apr 22

RT @angRchen: One thing changing in the survivor landscape is how many more patients are surviving cancers that previously may have been co…

Kevin McLaughlin
Kevin McLaughlin @CancerTodayEdit
12 Apr 22

RT @Rick__Buck: Our #AACR22 Survivorship Panel with ⁦@statnews⁩ going on now. Tune in. https://t.co/6hDaLiR9Po. Thanks ⁦@angRchen⁩ for coll…